Zhejiang Garden Bio-chemical High-tech Co., Ltd.

Zhejiang Garden Bio-chemical High-tech Co., Ltd. is a leading manufacturer in the food manufacturing sector, primarily focused on the production of vitamin D3 and its related products. Established with a strategy to build a complete upstream and downstream vitamin D3 industrial chain, the company has developed over two decades to become the only global manufacturer of vitamin D3. It is listed on the ChiNext board of the Shenzhen Stock Exchange since 2014 and has expanded its operations through strategic acquisitions, including the full ownership of Zhejiang Garden Pharmaceutical. The company's operations are divided into two main business sections: Vitamin D3 and Pharmaceutical Manufacturing. The Vitamin D3 section includes key products such as lanolin cholesterol, vitamin D3, and 25-hydroxyvitamin D3, which are essential for various applications in feed additives, food supplements, and pharmaceuticals. The Pharmaceutical Manufacturing section, through Garden Pharmaceutical, focuses on R&D, production, and sales of compounded products for chronic diseases, with a strong emphasis on cardiovascular and neurological treatments. The company has established a robust sales network across China and is recognized for its technological advancements and production capabilities in both sectors.

Vitamin D3 Sections 1、Advantages of the clear whole industry chain Since its inception, the company has set a clear development strategy since the Company established: "Build a complete upstream and downstream vitamin D3 industrial chain" which is the key factor in forming core competitiveness of the Company in the process of development. Bases on vitamin D3, the Company develops cholesterol and refined lanolin as upstream raw materials and gradually involves in the field of cosmetic materials, and involves in high-value added application field by the industrialization for products of 25-hydroxyvitamin D3 and environmental friendly rodenticide in downstream. In the future, the Company will enter the pharmaceutical and healthcare field by developing fully active vitamin D3 and analogues. 2、Advantages of Leading production technology. The Company owns three core leading production processes in the world: vitamin D3 production process, cholesterol NF grade production process and 25-hydroxyvitamin D3 production process. It has established a provincial high-tech R&D Centre, a provincial Academician Expert Workstation (Be rewarded as National Model Academician Expert Workstation) and a provincial postdoctoral workstation. We have improved our R&D strength and process technology level, and established the leading technological advantages in the industry by continuous investments in research and development. 3、Advantages of Lower production cost. The Company produces cholesterol NF from raw materials of wool grease by itself for vitamin D3 production, this is the large difference from other Vitamin D3 manufacturers in the industry, and leads to substantially lower production costs of vitamin D3 than other manufacturers in the industry. 4、Advantages of outstanding business scale The company is the leading manufacturer which is producing the largest variety for upstream and downstream of vitamin D3 products not only in China but also in the world, the Company is also the manufacturer producing both cholesterol NF and vitamin D3 products, the output and market share of vitamin D3 for the Company is at top in the world. 5、Advantages for well construction of market channel. The Company focus on quality management improvement as s a leading manufacturer of vitamin D3 in world. With developing of more than 20 years, the Garden brand is awarded of high reputation in the feed, food and pharmaceutical industries, etc. The company has has stable sales channels and customer relationships with established long-term and stable strategic cooperation with internationally renowned manufacturers and distributors. Pharmaceutical manufacturing Section 1、Products With market-driven products, Garden Pharmaceutical keeps focus on the R&D, production and sales of compounded products in the field of cardiovascular, neurological and other chronic diseases. The key products including Valsartan and Amlodipine Tablets （I）, Levofloxacin Tablets, Doxofillina Injection, Thioctic Acid Injection and Escitalopram Oxalate Tablets have obtained the drug registration certificate (deemed to have passed the consistency evaluation) and have been successfully selected for centralized volume-based procurement by National or regional alliances. 2、Research and Development Garden Pharmaceutical is a National high-tech Enterprise and has a provincial-level high-tech R&D center. It reached a number of technology achievements with new product R&D and technological innovation through the introduction of advanced technology and independent innovation, and formed a stable and sustainable product development echelon. 3、Market Development Garden Pharmaceutical has established a sales network covering most regions of China. Based on the different stages of the life cycle of various products and the different attributes of the products, we develop differentiated academic promotion programs for market cultivating finely, enhance the prescribing habits of doctors.